Portfolio company
Genespire
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops off-the-shelf gene therapies for children and adults affected by inherited metabolic diseases and primary immunodeficiencies.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Neurogene Inc
This company develops genetic medicines and gene therapies to treat patients and families affected by rare neurological diseases including Rett syndrome and Batten disease.
Immitra Bio
This company develops an in-vivo gene editing platform to provide off-the-shelf curative treatments for patients with rare genetic diseases.
Spur Therapeutics
This company develops adeno-associated virus gene therapies to treat chronic conditions including Gaucher disease and Parkinson's disease for patients with inherited genetic disorders.
Stridebio
This company develops engineered viral vectors and gene therapies for patients with rare genetic diseases.
GenSight Biologics
This company develops gene therapies for patients suffering from neurodegenerative retinal diseases and central nervous system disorders.
EdiTy Therapeutics
This company develops immune cell delivery platforms to transport therapeutic proteins into diseased cells for patients with cancer and genetic disorders.
Rampart Biosciences
This company develops non-viral, DNA-based gene medicines for patients with serious genetic disorders, specifically focusing on liver-related conditions like hypophosphatasia.
Alia Therapeutics
The company develops gene editing medicines for patients with genetic diseases.